FOCUSING on IMPROVING THE LIVES of PATIENTS WITH DIFFICULT-TO-TREAT DISEASES
BioMed Valley Discoveries reported new clinical research of first-in-class ERK-targeted cancer therapy ulixertinib (BVD-523) at the 2017 American Society of Clinical Oncology Annual Meeting.
COMBINING the EXPERTISE of our TEAM and our PARTNERS to BREAK THROUGH BARRIERS in EARLY STAGE DRUG DEVELOPMENT
MENU
ADDRESS
LINPING ZHANG, PhD, MBA
Executive Director, Translational Sciences
Dr. Zhang is an Executive Director of Translational Sciences at BioMed Valley Discoveries. Prior to joining BioMed Valley Discoveries, Linping was an Associate Director for Project Management at Novartis Institutes for BioMedical Research where she managed programs ranging from IND-enabling stage to phase II clinical development. Previously, Linping was a founding scientist and project leader at Infinity Pharmaceuticals with increasing responsibility in chemistry research and development.
Dr. Zhang earned her PhD in Medicinal Chemistry from the SUNY/Buffalo, and completed her postdoctoral training at Harvard University. She holds an MBA from the MIT Sloan School of Management as a Sloan Fellow.
JONATHAN S. THOMAS
President and Chief Executive Officer, American Century Investments
Mr. Jonathan S. Thomas is President and Chief Executive Officer of American Century Investments. Mr. Thomas joined American Century in 2005 as Chief Financial Officer and Executive Vice President, and a member of the American Century Companies Board of Directors. He became CEO in March 2007.
Prior to joining American Century, Mr. Thomas was Global Chief Operating Officer and Managing Director of the Investment Management division at Morgan Stanley in New York City. Mr. Thomas received a BA in Economics from the University of Massachusetts and a MBA from Boston College.
RODERICK L. STURGEON, MBA
Executive Vice President and Chief Financial Officer, Stowers Institute for Medical Research
Mr. Roderick L. Sturgeon is currently Executive Vice President and Chief Financial Officer of the Stowers Institute for Medical Research. Mr. Sturgeon joined the Stowers Institute in February 2007 from a position as Senior Vice President, Personal Expression Group Finance at Hallmark Cards, Inc.
Mr. Sturgeon received a bachelor’s degree from Kansas State University and a MBA from the University of Missouri, Kansas City. He serves on the Kansas State University Business College Advisory Board, the Community National Bank Board, and the American Century Investments Board.
WILLIAM B. NEAVES, PhD
President Emeritus, Stowers Institute for Medical Research
Dr. William B. Neaves is President Emeritus of the Stowers Institute for Medical Research. Previously, Dr. Neaves served as Chief Executive Officer of the Stowers Institute from 2000 to 2010. Prior to joining the Stowers Institute, he held various positions at the University of Texas Southwestern Medical Center at Dallas.
Dr. Neaves currently serves as a member of the Boards of Directors of the Stowers Institute for Medical Research, Stowers Resource Management, BioMed Valley Corporation, and BioMed Valley Discoveries. Dr. Neaves received an AB magna cum laude with highest honors in biology from Harvard College in 1966 and a PhD in anatomy from Harvard University in 1969.
BRENT L. KREIDER, PhD
Chief Operating Officer, BioMed Valley Discoveries, Inc.
Chief Operating Officer, Stowers Institute for Medical Research
Dr. Brent L. Kreider serves as Chief Operating Officer of both BioMed Valley Discoveries and the Stowers Institute for Medical Research. In his previous position as Vice President and Global Head of Scientific Operations at the Novartis Institutes for Biomedical Research, Dr. Kreider provided senior management oversight to scientific support functions at institute sites throughout North America, Europe, and Asia.
Prior to joining Novartis, he held senior leadership positions at three biotech companies. Dr. Kreider received a PhD in microbiology from the University of Pennsylvania and performed postdoctoral research at St. Jude Children’s Research Hospital.
CLIFFORD W. ILLIG
Vice Chairman and Co-Founder, Cerner Corporation
Mr. Clifford W. Illig is Vice Chairman of the Board and Co-Founder of Cerner Corporation, one of the world’s largest suppliers of healthcare information technology solutions, healthcare devices, and related services.
He focuses on growing and expanding Cerner’s market-oriented business units, key strategic relationships, and priority corporate initiatives. Mr. Illig serves some significant regional civic boards and organizations. Mr. Illig received a degree in accounting and business administration from the University of Kansas.
ABBY FREEMAN
Former Executive Vice President for Administration, Stowers Institute for Medical Research
Ms. Abby Freeman is the former Executive Vice President for Administration at the Stowers Institute for Medical Research. Prior to joining the Institute, Ms. Freeman held positions at The University of Texas Southwestern Medical Center at Dallas including Director of the Graduate School of Biomedical Sciences, Equal Opportunity and Minority Affairs Officer, and Vice President for Human Services Administration.
Ms. Freeman previously held leadership positions with the Young Women’s Christian Association (YWCA). Ms. Freeman earned a BA in business administration from Huston-Tillotson College in Austin, Texas. She serves as a member of the Boards of Directors of the Stowers Institute for Medical Research and American Century Companies.
DAVID M. CHAO, PhD
President and Chief Executive Officer, BioMed Valley Discoveries, Inc.
President and Chief Executive Officer, Stowers Institute for Medical Research
Dr. David M. Chao serves as President and Chief Executive Officer of BioMed Valley Discoveries and the Stowers Institute for Medical Research. Prior to joining BioMed Valley Discoveries, Dr. Chao was head of operations for strategic alliances at the Novartis Institutes for Biomedical Research. His previous positions also include co-founder and executive at two biotech start-ups and consultant at McKinsey & Company.
After receiving combined MA and BA degrees in biology from Harvard University, Dr. Chao received a Ph.D. in biology from the Massachusetts Institute of Technology where he was a predoctoral fellow of the Howard Hughes Medical Institute. He serves on the board of the Stowers Institute for Medical Research, American Century Companies, Nectagen, and the Pembroke Hill School.
RICHARD W. BROWN
Chairman of the Board, BioMed Valley Discoveries, Inc.
Chairman of the Board, American Century Companies, Inc.
Chairman of the Board, Stowers Institute for Medical Research and Stowers Resource Management
Mr. Richard W. Brown serves as Chairman of the Board for BioMed Valley Discoveries, American Century Companies, Stowers Institute for Medical Research, and Stowers Resource Management. Mr. Brown has also served as Chairman, President, and Chief Executive Officer of Stowers Resource Management and BioMed Valley Corporation.
Mr. Brown was previously President and Chief Executive Officer of Health Midwest from 1993 to March 2003. Mr. Brown received a MHA from the School of Medicine at Washington University in St. Louis, Missouri, and a BA in Biology from Phillips University.
ANNA GROOVER, PhD
Scientist, Translational Sciences
Dr. Anna Groover is a Scientist in the Translational Sciences group at BioMed Valley Discoveries, where she manages day-to-day clinical operations for clinical trials involving BVD-523, a selective, reversible, ERK1/2 inhibitor.
Anna joined BioMed Valley Discoveries after completing her PhD in anatomy and cell biology at the University of Kansas Medical Center. She received a BS degree in biology from Baylor University.
DEBORAH KNOERZER, MS
Associate Director, Translational Sciences
Deb Knoerzer is an Associate Director of Translational Sciences at BioMed Valley Discoveries. Prior to joining BioMed Valley Discoveries, Deb was Vice President of Research Operations for Horizon Discovery where she led the research operations for multiple sites within the US.
She has a vast range of experience in both small and large organizations, serving as Chief Operating Officer at SAGE labs and holding a variety of senior positions during her 19 years within the pharmaceutical industry including positions at Pfizer, Pharmacia, Searle, and Monsanto. Deb received a BS in biological sciences from Illinois State University and a MS in biological sciences from Washington University School of Medicine in St. Louis.
CAROLINE EMERY, PhD
Associate Director, Translational Sciences
Dr. Caroline Emery is an Associate Director of Translational Sciences at BioMed Valley Discoveries. Previously, Carrie held a position in early pharmaceutical development at Novartis Oncology, where she supported the evolution of novel agents into the clinic.
She earned her PhD in developmental genetics from the University of Oxford, UK, and completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard University, where she studied mechanisms of resistance to targeted therapies in melanoma. Carrie received a BSc degree in pathology and microbiology from the University of Bristol, UK.
HALLE (HUIHONG) ZHANG, RN, MMedSci, PhD
Director, Translational Sciences
Dr. Halle Zhang is a Director and Project Leader at BioMed Valley Discoveries, where she leads the clinical development of Clostridium novyi-NT, a bacterial oncolytic therapy. Prior to joining BioMed Valley Discoveries, Halle served as a Clinical Trial Lead within the Harvard Catalyst network.
Her previous positions also include LAM Foundation Research Fellow at Harvard TH Chan School of Public Health and Research Scientist at Tufts University, where she examined cell signaling in cancer and metabolic diseases. Halle is an RN with over ten years of clinical experience in medical, surgical, pediatric, and operating room settings. Halle received a Master in Medical Sciences in immunology and a PhD in medicine from the University of Birmingham, UK.
DEAN WELSCH, PhD
Executive Director, Translational Sciences, Head of Pharmacology
Dr. Dean Welsch is an Executive Director of Translational Sciences and Head of Pharmacology at BioMed Valley Discoveries. Prior to joining BioMed Valley Discoveries, Dean held positions of increasing responsibility in research and development at Monsanto, Searle, Pharmacia, and Pfizer.
Prior to leaving Pfizer, he was Senior Director and Research Fellow in the company’s Indications Discovery Unit, where he was responsible for identifying and validating through clinical proof-of-concept new indications for development compounds. Dean received a BS in Chemistry from Hope College, a PhD in Biochemistry from the University of Minnesota, and performed postdoctoral research in the lab of Dr. Paul Friedman at Merck Sharpe and Dohme Research Labs.
DAVID M. CHAO, PhD
President and Chief Executive Officer Member, Board of Directors
Dr. David M. Chao serves as President and Chief Executive Officer of BioMed Valley Discoveries and the Stowers Institute for Medical Research. Prior to joining BioMed Valley Discoveries, Dave was head of operations for strategic alliances at the Novartis Institutes for Biomedical Research. His previous positions also include co-founder and executive at two biotech start-ups and consultant at McKinsey & Company.
After receiving combined MA and BA degrees in biology from Harvard University, Dave received a PhD in biology from the Massachusetts Institute of Technology where he was a predoctoral fellow of the Howard Hughes Medical Institute. Dave serves on the board of the Stowers Institute for Medical Research, American Century Companies, Nectagen, and the Pembroke Hill School.
BRENT L. KREIDER, PhD
Chief Operating Officer Member, Board of Directors
Dr. Brent L. Kreider serves as Chief Operating Officer of both BioMed Valley Discoveries and the Stowers Institute for Medical Research. In his previous position as Vice President and Global Head of Scientific Operations at the Novartis Institutes for Biomedical Research, Brent provided senior management oversight to scientific support functions at Institute sites throughout North America, Europe, and Asia.
Prior to joining Novartis, he held senior leadership positions at three biotech companies. Brent received a PhD in microbiology from the University of Pennsylvania and performed postdoctoral research at St. Jude Children’s Research Hospital.
GARY DeCRESCENZO, MS
Executive Director, Head of Chemistry
Gary DeCrescenzo is Head of Chemistry at BioMed Valley Discoveries. Prior to joining BioMed Valley Discoveries, Gary was Senior Director of World Wide Medicinal Chemistry at Pfizer Inc, where he oversaw medicinal chemistry and early chemical development.
He previously held senior leadership positions in research and development at Pharmacia Corporation and GD Searle. Gary received a BS in Chemistry and a MS in industrial chemistry from the University of Central Florida.